Abstract
A 63-year-old man was admitted to our Oncology department for management of a follicular non-Hodgkin lymphoma, stage IV A FLIPI 5. The patient entered chemotherapy following the R-CHOP schedule, and a PET scan after three cycles showed partial remission. One week later he was admitted to our hospital after developing serious pain in his left arm resulting in an impaired function, right facial hemiplegia, and ophthalmoplegia. Neuroimaging studies and laboratory features were negative. Given his symptoms, we suspected Miller Fisher syndrome and the patient was administered high dose immunoglobulin, but showed no improvement. Finally, chemotherapy with methotrexate 3 g/mq was initiated, but his condition progressively worsened and the patient died 2 months later. We suggest that any patient with neurological symptoms who has received rituximab should undergo PCR analysis for all neurotropic viruses together with neurophysiological and neuroimaging studies.
This is a preview of subscription content, log in via an institution to check access.
References
Servais S, Caers J, Warling O, Frusch N, Baron F, De Prijck B, et al. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. Br J Haematol. 2010;150(3):379–81.
Kiani-Alikhan S, Skoulidis F, Barroso A, Nuovo G, Ushiro-Lumb I, Breuer J, et al. Enterovirus infection of neuronal cells post-Rituximab. Br J Haematol. 2009;146(3):333–5.
Ferrari A, Luppi M, Marasca R, Potenza L, Morselli M, Volzone F, et al. BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab. Eur J Haematol. 2008;81(3):244–5.
Terenghi F, Ardolino G, Nobile-Orazio E. Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma. J Periphern Nerv Syst. 2007;12(2):142–3.
Carmona A, Alonso JD. de las Heras M, Navarrete A. Guillain Barrè syndrome in a patient with diffuse large cell lymphoma and Rituximab maintenance therapy. An association beyond anecdotal evidence? Clin Transl Oncol. 2006;8(10):764–6.
Kemming JL, van Zeeland RE, Ullmann EF, Mattijssen EJ. Interstitial pneumonitis as a side effect of rituximab. Ned Tijdschr Geneeskd. 2009;153:A526.
Yi JH, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS. Rituximab-induced acute thrombocytopenia: a case report and review of the literature. Med Oncol. 2009;26(1):45–8.
Dass S, Vital EM, Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum. 2007;56(8):2715–8.
Gleissner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol. 2006;5(5):443–52. (Review).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Marino, D., Farina, P., Jirillo, A. et al. Neurological syndrome after R-CHOP chemotherapy for a non-Hodgkin lymphoma: what is the diagnosis?. Int J Hematol 94, 461–462 (2011). https://doi.org/10.1007/s12185-011-0942-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-011-0942-4